News
ABILITY Neurotech Set for First Chronic BCI Implant Trial in ALS Patients
The study will initially evaluate the performance of ABILITY’s BCI as a home-use system to restore communication and speech in ALS patients.
ADDRESS: Street, City, Country
PHONE: +(123) 456 789
E-MAIL: your-email@mail.com
The study will initially evaluate the performance of ABILITY’s BCI as a home-use system to restore communication and speech in ALS patients.
HealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.
Email Us: support@healthxploreindia.com
Contact: +91 8447496924
HealthXploreIndia @2026. All Rights Reserved.
